|
ZNF426 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63857816204427E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.16819920193257E-11 |
| Normal-vs-Stage2 |
5.7662999997099E-07 |
| Normal-vs-Stage3 |
4.54549953232686E-10 |
| Normal-vs-Stage4 |
9.47719680510772E-11 |
| Stage1-vs-Stage2 |
7.604400E-01 |
| Stage1-vs-Stage3 |
1.646400E-01 |
| Stage1-vs-Stage4 |
2.402100E-02 |
| Stage2-vs-Stage3 |
4.905200E-01 |
| Stage2-vs-Stage4 |
1.878390E-01 |
| Stage3-vs-Stage4 |
3.875000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.91668944341473E-14 |
| Normal-vs-AfricanAmerican |
1.700970E-03 |
| Normal-vs-Asian |
3.18949999744689E-08 |
| Caucasian-vs-AfricanAmerican |
2.268400E-01 |
| Caucasian-vs-Asian |
6.241200E-01 |
| AfricanAmerican-vs-Asian |
1.813220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99099958742011E-10 |
| Normal-vs-Female |
3.68716168708261E-12 |
| Male-vs-Female |
1.301990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.21510002060177E-09 |
| Normal-vs-Age(41-60Yrs) |
1.01629815674187E-12 |
| Normal-vs-Age(61-80Yrs) |
2.54209986394471E-11 |
| Normal-vs-Age(81-100Yrs) |
2.637800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.978020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.549020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.296200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.263200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.136400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.110200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.027700E-02 |
| Classical-VS-Follicular |
2.552500E-02 |
| Classical-VS-Other |
2.376600E-01 |
| Classical-VS-Normal |
4.51639836640538E-11 |
| Tall-VS-Follicular |
7.977600E-01 |
| Tall-VS-Other |
6.971600E-01 |
| Tall-VS-Normal |
2.86790002856918E-09 |
| Follicular-VS-Other |
6.705800E-01 |
| Follicular-VS-Normal |
5.16680032092154E-11 |
| Other-VS-Normal |
1.455040E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62347912890937E-12 |
| Normal-vs-N1 |
6.46919962044024E-10 |
| N0-vs-N1 |
1.749800E-01 |
|
|
